http://www.cnr.it/ontology/cnr/individuo/rivista/ID485716
Leukemia
- Label
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Cytogenetic and molecular characterization of a variant translocation associated with acute promyelocytic leukemia and involving chromosomes 11, 15 and 17 (Articolo in rivista) (Prodotto della ricerca)
- Looking for CALR mutations in familial myeloproliferative neoplasms (Articolo in rivista) (Prodotto della ricerca)
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. (Articolo in rivista) (Prodotto della ricerca)
- Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Defective class II transactivator expression in a B lymphoma cell line (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Quercetin enhances CD95 and TRAIL induced apoptosis in leukemia cell lines. (Articolo in rivista) (Prodotto della ricerca)
- Tumor necrosis factor ? down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of Acute Promyelocitic Leukemia cells (Articolo in rivista) (Prodotto della ricerca)
- Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukaemia, (Articolo in rivista) (Prodotto della ricerca)
- Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients, (Articolo in rivista) (Prodotto della ricerca)
- Multifaceted roles of GSK-3 and Wnt/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. (Articolo in rivista) (Prodotto della ricerca)
- Significant reduction of the hybrid BCR/ABL transcripts after inducyion and consolidation therapy is a powerful predictor of tratmnt response in adult Philadelphia-positive acute lymbophoblastic leukemia (Articolo in rivista) (Prodotto della ricerca)
- Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. (Articolo in rivista) (Prodotto della ricerca)
- The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. (Articolo in rivista) (Prodotto della ricerca)
- Increase of CCR7- CD45RA+ CD8 T cells (T(EMRA)) in chronic graft-versus-host disease. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Immunophenotypic, cytogenetic and functional characterization of circulating of endothelial cells in myelodysplastics syndromes (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same famil (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. (Articolo in rivista) (Prodotto della ricerca)
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. (Articolo in rivista) (Prodotto della ricerca)
- PKR is activated in MDS patients and its subcellular localization depends on disease severity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Synergistic induction of PI-PLC²1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoies (Articolo in rivista) (Prodotto della ricerca)
- Tumor necrosis factor ? modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. (Articolo in rivista) (Prodotto della ricerca)
- A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Alternative label
- Language
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn
- Preferred label
- Publisher
- Williams & Wilkins, [Baltimore, Md.] : USA (literal)
Incoming links:
- Rivista
- Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients, (Articolo in rivista) (Prodotto della ricerca)
- Increase of CCR7- CD45RA+ CD8 T cells (T(EMRA)) in chronic graft-versus-host disease. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Defective class II transactivator expression in a B lymphoma cell line (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. (Articolo in rivista) (Prodotto della ricerca)
- Synergistic induction of PI-PLC²1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoies (Articolo in rivista) (Prodotto della ricerca)
- Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. (Articolo in rivista) (Prodotto della ricerca)
- Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukaemia, (Articolo in rivista) (Prodotto della ricerca)
- Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Immunophenotypic, cytogenetic and functional characterization of circulating of endothelial cells in myelodysplastics syndromes (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. (Articolo in rivista) (Prodotto della ricerca)
- PKR is activated in MDS patients and its subcellular localization depends on disease severity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. (Articolo in rivista) (Prodotto della ricerca)
- A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of Acute Promyelocitic Leukemia cells (Articolo in rivista) (Prodotto della ricerca)
- Significant reduction of the hybrid BCR/ABL transcripts after inducyion and consolidation therapy is a powerful predictor of tratmnt response in adult Philadelphia-positive acute lymbophoblastic leukemia (Articolo in rivista) (Prodotto della ricerca)
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Quercetin enhances CD95 and TRAIL induced apoptosis in leukemia cell lines. (Articolo in rivista) (Prodotto della ricerca)
- Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same famil (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. (Articolo in rivista) (Prodotto della ricerca)
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. (Articolo in rivista) (Prodotto della ricerca)
- Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Looking for CALR mutations in familial myeloproliferative neoplasms (Articolo in rivista) (Prodotto della ricerca)
- Multifaceted roles of GSK-3 and Wnt/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. (Articolo in rivista) (Prodotto della ricerca)
- Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytogenetic and molecular characterization of a variant translocation associated with acute promyelocytic leukemia and involving chromosomes 11, 15 and 17 (Articolo in rivista) (Prodotto della ricerca)
- Tumor necrosis factor ? down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Tumor necrosis factor ? modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
